Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis

BACKGROUND: In analyzing cancer patient survival data, the problem of competing risks is often ignored. This study used a competing risk approach to evaluate the efficacy of recombinant human type-5 adenovirus (H101) in patients with hepatocellular carcinoma (HCC) treated by transarterial chemoembol...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Chaobin, Zhang, Yu, Lin, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978816/
https://www.ncbi.nlm.nih.gov/pubmed/29435900
http://dx.doi.org/10.1007/s11605-018-3703-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978816/
https://www.ncbi.nlm.nih.gov/pubmed/29435900
http://dx.doi.org/10.1007/s11605-018-3703-3

Ejemplares similares